期刊文献+

肝门部胆管癌的预后影响因素探讨

下载PDF
导出
摘要 目的探讨影响肝门部胆管癌术后的预后因素。方法回顾性收治的86例肝门部胆管癌的临床资料,分析影响肝门部胆管癌预后的因素。结果分化较好组48例(乳头状腺癌22例、高分化腺癌26例),生存期为(21.3±3.0)个月;分化较差组38例(低分化腺癌21例、未分化癌5例、黏液腺癌12例),生存期为(5.1±0.8)个月,两组比较差异有统计学意义(P<0.05)。不同治疗方式的死亡率比较差异无统计学意义(P>0.05)。切除组(包括根治性切除和姑息性切除)的术后生存期为(19.4±2.2)个月,引流组(包括内引流和外引流)则为(7.2±1.2)个月,两组比较差异有统计学意义(P<0.05)。TNM临床分期Ⅰ、Ⅱ期者共28例,生存期为(27.4±2.1)个月;Ⅲ、Ⅵ期共58例,生存期为(8.8±1.0)个月,两组比较差异有统计学意义(P<0.05)。结论肝门部胆管癌的预后与组织学分型、手术治疗方式、肿瘤的分期等因素密切相关。
出处 《中国现代药物应用》 2008年第24期105-106,共2页 Chinese Journal of Modern Drug Application
  • 相关文献

参考文献11

  • 1[1]Santoro E,Sachi M,Carbonif,et al.Klaskin tumor:A study of 15 resected cases.Chirurgic,1999,124 (2):139.
  • 2[2]Bismuth H,Castaing D,Traynor O.Resection or palliation:priority of surgery in the treatment of hilar cancer.World Surg,1988,12 (1):39-47.
  • 3[3]Sobin LH,Wittekind C,Hermanek P,et al.TNM classification of malignant tumors:international union against cancer.5thed.New York:WileyLiss Inc,1997,74-83.
  • 4彭淑牖.努力提高胆道系统恶性肿瘤的诊治水平[J].中国普通外科杂志,2001,10(1):2-5. 被引量:24
  • 5何振平,郑树国,董家鸿,蔡景修,韩本立,别平,王曙光,李智华,刘永雄,黄志强.肝门部胆管癌的外科治疗(附181例报告)[J].中华肝胆外科杂志,1999,5(6):368-372. 被引量:33
  • 6[6]Mabariaga J R,Fung J,Gutierrez J,et al.Liver resection combined wit h excision of vena cava.J Am Col l Surg,2000,191(3):244-250.
  • 7[7]Chamberlain RS,B lumgart LH.Hilar cholangiocarcinoma:a review and commentary.Ann Surg Oncol,2000,7(1):55-66.
  • 8[8]Hasegawa S,Ikaii,Fujii H,et al.Surgical resection of hilar cholangiocarcinoma:analysis of survival and postoperative comp lications.World J Surg,2007,31(6):1256-1263.
  • 9[9]Miyazakim,Kato A,Ito H,et al.Combined vascular resection in operative resection for hilar cholangiocarcinoma:does it work or not.Surgery,2007,141(5):581-588.
  • 10程庆保,张柏和,张永杰,姜小清,张宝华,易滨,俞文隆,吴孟超.肝门部胆管癌预后因素分析[J].肿瘤,2005,25(2):166-169. 被引量:26

二级参考文献6

  • 1Capussotti L, Muratore A, Polastri R, et al. Liver resection for hilar cholangiocarcinoma: in-hospital mortality and longterm survival[J]. J Am Coll Surg, 2002, 195(5):641-647.
  • 2Munoz L, Roayaie S, Maman D, et al. Hilar cholangiocarcinoma involving the portal vein bifurcation: long term results after resection[J]. J Hepatobiliary Pancreat Surg, 2002, 9(2) :237-241.
  • 3Cheng JL,Bruno MJ, Bergman JJ, et al. Endoscopic palliation of patients with biliary obstruction caused by nonresectable hilar cholangiocarcinoma: efficacy of self expandable metallic Wallstents[J]. Gastrointest Endosc, 2002, 56(1) :33 -39.
  • 4Bathe OF, Pacheco JT, Ossi PB, et al. Management of hilar bile duct carcinoma [J]. Hepatogastroenterology, 2001, 48(41) :1289-1294.
  • 5周宁新,黄志强,冯玉泉,顾万清,蔡守旺,张文智,黄晓强,段云鹏,王敬,纪文斌.肝门部胆管癌103例外科治疗远期疗效的评析[J].中华外科杂志,1997,35(11):649-653. 被引量:110
  • 6周宁新,黄志强,冯玉泉,顾万清,张文智,黄晓强.肝门部胆管癌根治性切除手术方式的改进[J].中华普通外科杂志,2001,16(2):82-84. 被引量:72

共引文献74

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部